Does higher hematocrit increase blood viscosity and hinder capillary flow?

Higher hematocrit, impaired red-cell deformability, and possibly greater red-cell size variability can interact to compromise blood flow—particularly in the microcirculation, where shear is low and erythrocytes must repeatedly deform to enter narrow capillaries.

Rheology and microvascular flow

• Higher hematocrit is a well-established cause of increased whole-blood viscosity. In direct measurements from 43 fresh blood samples, including polycythemia vera and secondary polycythemia, viscosity increased sharply with hematocrit at shear rates of 12–120 s⁻¹. Near a hematocrit of 70%, viscosity was approximately 20 cP at 12 s⁻¹ and 12 cP at 120 s⁻¹.
• This relationship is nonlinear and most pronounced at low shear. Higher cell concentration promotes erythrocyte contact and aggregation; aggregation further increases viscosity. Plasma viscosity and red-cell properties modify the magnitude, so hematocrit alone does not fully predict an individual’s rheology.

Deformability, oxygenation, and mechanism

• Reduced erythrocyte deformability can directly impair capillary passage and perfusion. Rigidified cells reduce functional capillary density in experimental models and increase microvascular flow resistance in microfluidic systems.
• In an acute-anemia hamster model, rigidified-cell transfusion reduced both functional capillary density and tissue oxygen tension versus normal cells. Mechanistically, impaired deformation alters capillary entry, red-cell partitioning between branches, transit time, and local hematocrit—all determinants of oxygen flux.
• Greater red-cell size variability (high RDW/anisocytosis) is associated with lower deformability and may worsen uneven capillary transit or preferential shunting of larger cells. However, its independent causal effect on capillary flow or tissue oxygen delivery remains plausible rather than directly established; RDW can also reflect anemia, inflammation, or red-cell injury.

Bottom line

• Higher hematocrit reliably raises blood viscosity; reduced red-cell deformability has experimental support for impairing capillary perfusion and tissue oxygenation. Increased size variability may add to this microvascular burden, but should currently be interpreted primarily as a mechanistic possibility and clinical marker rather than a proven independent cause.